Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Gimatecan by Lee's Pharmaceutical for Epithelial Ovarian Cancer: Likelihood of Approval
Gimatecan is under clinical development by Lee's Pharmaceutical and currently in Phase II for Epithelial Ovarian Cancer. According to GlobalData,...
Gimatecan by Lee's Pharmaceutical for Metastatic Pancreatic Cancer: Likelihood of Approval
Gimatecan is under clinical development by Lee's Pharmaceutical and currently in Phase II for Metastatic Pancreatic Cancer. According to GlobalData,...
Gimatecan by Lee's Pharmaceutical for Fallopian Tube Cancer: Likelihood of Approval
Gimatecan is under clinical development by Lee's Pharmaceutical and currently in Phase II for Fallopian Tube Cancer. According to GlobalData,...
Gimatecan by Lee's Pharmaceutical for Peritoneal Cancer: Likelihood of Approval
Gimatecan is under clinical development by Lee's Pharmaceutical and currently in Phase II for Peritoneal Cancer. According to GlobalData, Phase...